GlassScriptPhysician profile
James V Winkley
NPI 1467400432
$6,455.76
in general payments reported to CMS, 2019-2025
34 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $1,322 · 2021: $220 · 2022: $706 · 2023: $400 · 2024: $2,289 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,152 · Travel and Lodging: $674 · Education: $60.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,152.27 |
| Travel and Lodging | $673.89 |
| Education | $60.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,549.95 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Nevro Corp. | $1,433.41 | 2019-2024 | Senza |
| Becton, Dickinson and Company | $960.00 | 2020 | |
| Spr Therapeutics, INC | $367.61 | 2024-2025 | Sprint Pns System |
| Globus Medical, INC. | $365.02 | 2025 | Senza |
| Mml US, INC. | $194.45 | 2025 | Reactiv8 |
| Curonix LLC | $182.66 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $154.43 | 2020 | |
| Vertos Medical, INC. | $143.74 | 2019-2022 | |
| Emd Serono, INC. | $129.19 | 2020-2023 | Mavenclad |
| Abbott Laboratories | $117.27 | 2019-2024 | Eterna |
| Stryker Corporation | $115.21 | 2025 | Mild Device Kit |
| Merck Sharp & Dohme LLC | $112.69 | 2021-2025 | Bridion |
| Collegium Pharmaceutical, INC. | $92.42 | 2023-2025 | Belbuca |
| Vertex Pharmaceuticals Incorporated | $51.71 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $44.99 | 2024-2025 | Hyqvia |
| Stimwave Technologies Incorporated | $43.82 | 2022 | |
| Medtronic, INC. | $41.66 | 2021-2022 | |
| Biogen, INC. | $39.78 | 2025 | Leqembi |
| Azurity Pharmaceuticals, INC. | $37.71 | 2024 | Horizant |
| Chiesi USA, INC. | $34.48 | 2019 | |
| Si-Bone, INC. | $23.83 | 2022 | |
| Valinor Pharma, LLC | $23.42 | 2025 | Movantik |
| Masimo Corporation | $22.11 | 2021 | |
| Mdd US Operations, LLC | $21.71 | 2019 | |
| Abbvie INC. | $20.96 | 2022 | |
| Trevena, INC. | $20.38 | 2022 | |
| Daiichi Sankyo INC. | $18.41 | 2019 | |
| Edwards Lifesciences Corporation | $17.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.84 | 2019 | |
| Eagle Pharmaceuticals, INC. | $15.33 | 2023 | |
| Zyla Life Sciences, INC. | $14.98 | 2020 | |
| Medtronic USA, INC. | $14.05 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Winkley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.